InvestorsHub Logo
Followers 832
Posts 119787
Boards Moderated 17
Alias Born 09/05/2002

Re: HAK41 post# 780

Friday, 04/22/2011 12:46:12 PM

Friday, April 22, 2011 12:46:12 PM

Post# of 890

Since BG-12 could cut into future sales of all present MS drugs including Elan's, they need to hope that it works better than Pfizer's attempt at taking the oral route of administering the drug.

You’re mixing up two stories. PFE’s oral drug mentioned in the article you posted is for RA , not MS.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”